HIV Testing and Counseling in STD Clinics: an Adaptation of CTN 0032

描述（由申请人提供）：使HIV检测成为常规是美国主要的HIV预防策略之一。疾病控制和预防中心最近建议，在医疗机构中，预防咨询不需要作为艾滋病毒筛查项目的一部分，除非是作为对检测结果呈阳性的人进行事后咨询的一部分。这一政策建议一直存在争议，政策制定者、研究人员和公共卫生官员对常规HIV检测前咨询的必要性和效果存在分歧。自在卫生保健或非卫生保健环境中实施快速艾滋病毒检测以来，没有开展前瞻性研究，评估有咨询和没有咨询的快速艾滋病毒检测对接受检测（即增加了解其艾滋病毒状况的人数）、减少危险行为和减少包括艾滋病毒在内的新发性传播感染的影响。在此背景下，本提案旨在适应我们目前在NIDA临床试验网络（CTN）主持下进行的研究。CTN 0032是一项在药物滥用治疗项目中进行的随机对照多中心艾滋病毒检测和咨询试验，旨在确定最有效的艾滋病毒检测和咨询策略，以(1)增加了解自己艾滋病毒血清状态的人数，(2)减少他们的危险行为。我们提出的研究将使用CTN 0032中创建的基础设施来对艾滋病毒感染风险极高的人群进行研究：性病诊所的患者。在我们对CTN 0032的改编中，我们建议评估(1)现场HIV快速检测与(2)现场HIV快速检测的相对疗效和成本效益，现场HIV快速检测提供简短的、针对参与者的预防咨询与(2)现场HIV快速检测仅提供信息（根据CDC指南的建议）。我们将评估咨询对两个主要结果的影响：性传播感染发生率和接受6个月随访时的艾滋病毒检测结果。次要结果将是减少性危险行为、性行为中的物质使用以及咨询和检测的成本和成本效益。我们将在美国的9家性病诊所招募5000名参与者。我们将在HIV感染风险最高的人群中进行亚组疗效分析，包括男同性恋者、18-25岁人群和非洲裔美国人。这项研究将在2年内完成，因为我们将使用已经为CTN 0032开发和实施的研究基础设施，已经到位的站点，以及已经建立了良好和富有成效的工作关系的pi和研究团队。这项研究在NIDA网站的临床试验网络下被指定为高科学优先领域：增加NIDA药物滥用治疗临床试验网络试验结果的影响。为了与《美国复苏法案》的目标保持一致，这项研究将通过在多个州的公共卫生诊所雇用多名工作人员来提供经济效益，包括许多受经济衰退影响最严重的州。

DESCRIPTION (provided by applicant): Making HIV testing routine is one of the major HIV prevention strategies in the United States. The Centers for Disease Control and Prevention recently recommended that prevention counseling not be required as part of HIV screening programs in medical care settings, except as part of post-counseling for persons who have a positive test result. This policy recommendation has been controversial, and there is disagreement among policy makers, researchers, and public health officials about the need for and effect of routine pre-test counseling with HIV testing. There have been no prospective studies since the implementation of rapid HIV testing in either health care or non-health care settings that have evaluated the effect of rapid HIV testing with and without counseling on acceptance of testing (i.e., increasing the number of persons who learn their HIV status), reduction of risk behaviors and decreasing new sexually transmitted infection including HIV. Within this context, this proposal seeks to adapt our current study that is being conducted under the auspices of the NIDA Clinical Trials Network (CTN). CTN 0032 is a randomized controlled multi-center HIV testing and counseling trial conducted in substance abuse treatment programs to determine the most effective HIV testing and counseling strategy to (1) increase the numbers of persons who know their HIV serostatus and (2) decrease their risk behaviors. Our proposed study will use the infrastructure created in CTN 0032 to conduct the study on a population that is at an extreme high risk for HIV infection: patients at STD clinics. In our adaptation of CTN 0032, we propose to assess the relative efficacy and cost-effectiveness of (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling vs. (2) on-site HIV rapid testing with information only (as recommended in the CDC guidelines). We will evaluate the effect of counseling on two primary outcomes: STI incidence and receipt of HIV test results at 6-month follow-up. Secondary outcomes will be reduction of sexual risk behaviors, substance use during sex, and cost and cost-effectiveness of counseling and testing. We will enroll 5,000 participants at 9 STD clinics in the US. We will conduct subgroup efficacy analyses among persons at highest risk for HIV, including MSM, persons 18-25, and African- Americans. This study will be completed in a 2 year period since we will be using the research infrastructure that has been developed and implemented for CTN 0032, the sites already in place, and the PIs and research teams that have established excellent and productive working relationships. This research was designated as an area of high scientific priority on the NIDA website under the Clinical Trials Network: Increasing the Impact of Trial Results from the NIDA Drug Abuse Treatment Clinical Trials Network. In keeping with the goals of the American Recovery Act, the study will provide economic benefits by employing multiple staff at public health clinics in multiple states, including many of those hit hardest by the recession. PUBLIC HEALTH RELEVANCE: The adaptation of CTN 0032 to include sexually transmitted disease clinics will enable the rapid evaluation of the role of counseling on STI incidence and HIV testing rates in settings that provide medical care to patients at high risk for HIV. Importantly, we will include an economic component of this study that will allow us to determine whether counseling and testing, compared to testing alone, is cost-effective. The results of this study will be used to shape future HIV testing and prevention policies in the United States.